Insider · CIK 0001587114

EcoR1 Capital, LLC

CIK 0001587114 Name as filed on the most recent filing

Filed as EcoR1 Capital, LLC (54)

133 transaction lines · from 54 filings · filed 2014-03-28 to 2026-05-11 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

68 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-04-12 P, Open-market purchase Nuvation Bio Inc.NUVB 158,873, acquired Open Form 4 filing 0001567619-21-007976
2021-04-09 P, Open-market purchase Panacea Acquisition Corp. IIPANA 5,450,000, acquired Open Form 4 filing 0001213900-21-021365
2021-04-09 P, Open-market purchase Nuvation Bio Inc.NUVB 2 lines 3,009,180, acquired Open Form 4 filing 0001567619-21-007976
2021-03-31 S, Open-market sale Nuvation Bio Inc.NUVB 1,583,635, acquired Open Form 4 filing 0001567619-21-021329
2021-03-31 P, Open-market purchase Nuvation Bio Inc.NUVB 1,583,635, acquired Open Form 4 filing 0001567619-21-021329
2021-03-24 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 18,156,250, acquired Open Form 4 filing 0001567619-21-006927
2021-03-09 P, Open-market purchase Anaptysbio, IncANAB 9,928,426, acquired Open Form 4 filing 0001567619-21-006040
2021-03-08 P, Open-market purchase Anaptysbio, IncANAB 52,694,310, acquired Open Form 4 filing 0001567619-21-006040
2021-02-24 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 237,867, acquired Open Form 4 filing 0001567619-21-004963
2021-02-23 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 934,518, acquired Open Form 4 filing 0001567619-21-004963
2021-02-23 P, Open-market purchase Anaptysbio, IncANAB 751,657, acquired Open Form 4 filing 0001567619-21-004961
2021-02-18 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 1,043,075, acquired Open Form 4 filing 0001567619-21-004660
2021-02-18 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 162,103, acquired Open Form 4 filing 0001567619-21-004588
2021-02-17 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 4,665,542, acquired Open Form 4 filing 0001567619-21-004320
2021-02-16 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 2,031,967, acquired Open Form 4 filing 0001567619-21-004320
2021-02-12 P, Open-market purchase Prothena Corp Public Ltd CoPRTA 2 lines 6,959,761, acquired Open Form 4 filing 0001567619-21-004320
2020-09-01 S, Open-market sale Surface Oncology, Inc.SURF 2,376,681, disposed Open Form 4 filing 0001567619-20-016420
2020-07-06 P, Open-market purchase Panacea Acquisition CorpPANA 3,900,000, acquired Open Form 4 filing 0001213900-20-016762
2020-06-30 P, Open-market purchase Akouos, Inc.AKUS 19,992,000, acquired Open Form 4 filing 0001567619-20-012870
2014-05-27 P, Open-market purchase Genvec IncGNVC 2 lines 21,620, acquired Open Form 4 filing 0000921895-14-001307
2014-05-23 P, Open-market purchase Genvec IncGNVC 2 lines 10,095, acquired Open Form 4 filing 0000921895-14-001307
2014-05-22 P, Open-market purchase Genvec IncGNVC 2 lines 22,367, acquired Open Form 4 filing 0000921895-14-001307
2014-03-28 P, Open-market purchase Genvec IncGNVC 2 lines 129,849, acquired Open Form 4 filing 0000921895-14-000680
2014-03-27 P, Open-market purchase Genvec IncGNVC 2 lines 127,643, acquired Open Form 4 filing 0000921895-14-000680
2014-03-26 P, Open-market purchase Genvec IncGNVC 2 lines 54,490, acquired Open Form 4 filing 0000921895-14-000680

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 47
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. EcoR1 Capital, LLC, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001587114

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.